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Comparison of diagnostic accuracy of 64-slice computed
tomography coronary angiography in patients with low,
intermediate, and high cardiovascular risk
Abstract
RATIONALE AND OBJECTIVES: The aim of this study was to compare the diagnostic accuracy of
64-slice computed tomographic coronary angiography (CTCA) in groups of patients with low,
intermediate, and high risk for coronary artery disease (CAD) events. MATERIALS AND METHODS:
The institutional review board approved this study; written informed consent was obtained from all
patients. Eighty-eight consecutive patients with suspected CAD (40 women; mean age, 64.3 +/- 9.4
years; range, 39-82) underwent CTCA, calcium scoring, and invasive coronary angiography and were
grouped according to their Framingham 10-year risk for hard coronary events into low (<10%),
intermediate (10%-20%), and high (>20%) risk categories. Significant stenoses (luminal diameter
narrowing > or =50%) were assessed on an intention-to-diagnose-basis; no coronary segment was
excluded and nonevaluative segments were rated false positive. To determine differences between
groups, Kruskal-Wallis tests were performed for individually determined values of diagnostic
performance. RESULTS: Per-patient sensitivity, specificity, negative predictive, and positive predictive
values were 90.0%, 79.2%, 95.0%, and 64.3%, respectively, with low (n = 34), 87.5%, 92.3%, 85.7%,
and 93.3%, respectively, with intermediate (n = 29), and 100%, 75.0%, 100%, and 89.5%, respectively,
with high risk (n = 25), with a trend toward higher positive predictive value (P = .07). Per-segment
negative predictive value was lower with high pretest probability (P < .01). Mean calcium-score units
were 90, 220, and 312 (P = .23), and the prevalence of CAD was 29.4%, 55.2%, and 68.0% (P < .01)
with low, intermediate, and high risk. CONCLUSION: Sensitivity and specificity of CTCA are not
influenced by the prevalence of CAD, whereas the negative predictive value is lower and the positive
predictive value tends to be higher in patients with a high prevalence of CAD.
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low, intermediate, and high risk.
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Academic Radiology, Vol 15, No 4, April 2008 ACCURACY OF CT CORONARY ANGIOGRAPHYSixty-four–slice computed tomography (CT) has been
shown to be a reliable noninvasive tool to document or
rule out significant coronary artery lesions (1–10). In par-
ticular, the high negative predictive value (NPV) of CT
coronary angiography (CTCA), demonstrated in all stud-
ies (1–10), has been suggested to obviate the need for
invasive coronary angiography (ICA) in patients whose
symptoms or abnormal stress test results require ruling
out the presence of coronary artery disease (CAD) (11).
Although some guidelines (12) allow consideration of
CTCA in patients with a low pretest probability, others
have suggested CTCA as an appropriate tool in patients
with an intermediate risk for CAD (11,13). In high pretest
populations, CTCA is not considered a useful tool, be-
cause the likelihood for the necessity of a subsequent ICA
is high.
However, most studies that determined the diagnostic
accuracy of 64-slice CTCA have included patients with
known CAD (1,2,6–8) and patient cohorts with high
prevalences of CAD (56%–85%) (1–3,5,6,8,10), not tak-
ing into account the pretest probability or the risk to de-
velop coronary events in those patients with suspected
CAD (1–10).
Therefore, the purpose of our study was to determine
and compare the diagnostic accuracy of 64-slice CTCA in
groups of patients with low, intermediate, and high risk
for CAD events.
MATERIALS AND METHODS
Patients
Eighty-eight consecutive patients suspected of having
CAD (40 women and 48 men; mean age, 64.3  9.4
years; range, 39–82) were scheduled for CTCA and ICA,
provided there were no reasons for exclusion, such as
allergy to iodinated contrast agent, renal insufficiency
(creatinine levels 150 mol/L), nonsinus rhythm, or
hemodynamic instability. The patients were referred be-
cause of dyspnea (n  22), typical angina pectoris (n 
31), or atypical chest pain (n  19), or to preoperatively
rule out CAD (n  16). Framingham risk scoring was
assessed, using the factors of age, gender, low- and high-
density lipoprotein cholesterol levels, systolic and dia-
stolic blood pressure, diabetes, and nicotine abuse. The 10-
year risk for hard coronary heart disease events was deter-
mined as described in the National Cholesterol Education
Program’s Adult Treatment Panel III report (14), and pa-
tients were categorized into groups with low (10-year risk10%), intermediate (10-year risk 10%–19%), and high
(10-year risk 20%) risk for CAD events.
The study protocol was approved by the local ethics
committee, and written informed consent was obtained
from all patients.
CT Data Acquisition and Postprocessing
All CT examinations were performed on a 64-slice CT
scanner (Somatom Sensation 64; Siemens Medical Solu-
tions, Forchheim, Germany). For coronary calcium scor-
ing, a nonenhanced, retrospectively electrocardiographi-
cally-gated scan was performed using the following scan-
ning parameters: detector collimation of 32  0.6 mm,
slice acquisition of 64  0.6 mm using a z-flying focal
spot, pitch of 0.2, gantry rotation time of 330 msec, tube
voltage of 120 kV, and an effective tube-current time
product of 60 mA. Intravenous metoprolol (5 to 20 mg,
Beloc; AstraZeneca, London, UK) was administered prior
to the CTCA examination to achieve a target heart rate
70 beats/min, if necessary. In the presence of contrain-
dications for -adrenoceptor antagonists or when the
maximum dose did not lower the heart rate satisfactorily,
the scan was performed even at higher heart rates. In ad-
dition, all patients received a single dose of 2.5 mg
isosorbiddinitrate sublingual (Isoket; Schwarz Pharma,
Monheim, Germany) 2 minutes before the scan. The
CTCA examination was started by continuously injecting
a bolus of 80 ml of iodixanol (Visipaque 320, 320 mg/ml;
GE Healthcare, Buckinghamshire, UK) followed by 30 ml
of saline solution into an antecubital vein via an 18-gauge
catheter (injection rate, 5 ml/sec). Bolus tracking was per-
formed with a region of interest placed into the ascending
aorta, and image acquisition was automatically started 5
seconds after the signal density reached a predefined
threshold of 100 Hounsfield units. Scanning was per-
formed from 1 cm below the level of the tracheal bifurca-
tion to the diaphragm in a craniocaudal direction using
the following scanning parameters: detector collimation
32  0.6 mm, slice collimation 64  0.6 mm using a
z-flying focal spot, gantry rotation time of 330 msec,
pitch of 0.2, tube potential of 120 kV, and tube-current
time product of 650 effective mA. The electrocardiogram
was digitally recorded during data acquisition and was
stored with the unprocessed CT dataset.
CT Image Reconstruction and Analysis
Synchronized to the electrocardiographic data, CT data
sets were retrospectively reconstructed throughout the
entire cardiac cycle in 5% steps of the RR interval. When
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HUSMANN ET AL Academic Radiology, Vol 15, No 4, April 2008automatic positioning of the R-wave indicators by the
software failed, manual repositioning of the indicators
was performed. In case of irregular heart rates, the tempo-
ral variability in the reconstruction phase was compen-
sated by manual electrocardiographic editing. In case of
premature heartbeats, the temporal window of the follow-
ing heartbeat was deleted, and the next diastolic window
was filled with one to three temporal windows to avoid
data gaps. The adaptive cardiovolume approach was used
for image reconstruction, which automatically switches
between one- and two-segment reconstruction depending
on the patient’s heart rate (15). Reconstruction of axial
images was performed with a slice thickness of 1.0 mm
and an increment of 0.8 mm. All images were recon-
structed using a medium-soft and a sharp tissue convolu-
tion kernel (B30f and B46f) and were transferred to an
external workstation (Leonardo; Siemens Medical Solu-
tions).
For analysis of CTCA data, coronary arteries were seg-
mented as suggested by the American Heart Association
(16): The right coronary artery was defined to include
segments 1–4, the left main artery and the left anterior
descending artery to include segments 5–10, and the left
circumflex artery to include segments 11–15. The inter-
medial artery was designated as segment 16, if present.
All segments with a diameter of at least 1.5 mm at their
origin were included.
One reader (L.H.) semiquantitatively assessed the over-
all image quality in the best reconstruction interval on a
5-point scale, based on a previously published score (17)
(1, no artifacts; 2, mild artifacts; 3, moderate artifacts; 4,
severe artifacts; 5, nonevaluative) and determined the re-
construction interval with the best image quality. Two
independent readers (L.H., H.A.) evaluated and classified
coronary arteries, using axial source images, multiplanar
reformations, and thin-slab maximum-intensity projections
on a per-segment basis. Both readers assessed all coro-
nary artery segments for the presence of significant steno-
ses, defined as narrowing of the coronary luminal diame-
ter 50%. For any disagreement in data analysis between
the two observers, consensus agreement was achieved.
Diagnostic accuracy of CTCA was determined on an “in-
tention-to-diagnose” basis; no coronary segment was ex-
cluded, and nonevaluative segments were rated as false
positive.
Invasive Coronary Angiography
ICA was performed according to standard techniques,and multiple views were stored on a CD-ROM. The an-
454giograms were evaluated by two experienced observer in
consensus (O.G., P.K.), blinded to the results from
CTCA. Coronary artery segments were defined as previ-
ously mentioned (16), and analysis was performed in all
vessels with a luminal diameter of at least 1.5 mm, ex-
cluding those vessels distal to complete occlusions. Each
vessel segment was scored as being significantly stenosed,
defined as a diameter reduction of 50%.
Statistical Analysis
Quantitative variables were expressed as mean  stan-
dard deviation, and categorical variables as frequencies,
median (25th and 75th percentiles), or percentages. SPSS
software (version 12.0.1; SPSS, Chicago, IL) was used
for statistical testing (L.H.). Sensitivity, specificity, posi-
tive predictive value (PPV), NPV, and accuracy in the
identification of stenoses were assessed on a per-segment,
per-vessel, and per-patient basis using cross tables. ICA
was considered the standard of reference.
Differences between the three groups regarding diag-
nostic performance were tested for significance using 2
tests for comparison of cross tables. For further compari-
son, univariate analyses of variances (ANOVAs) were
performed for the following variables: age, body mass
index, low- and high-density lipoprotein, diastolic and
systolic blood pressure, heart rate, and heart rate variabil-
ity. Kruskal-Wallis tests were performed for calcium
score, Framingham risk score and 10%-year risk, image
quality, and best reconstruction interval. and 2-tests were
performed for gender, diabetes, nicotine abuse, and preva-
lence of CAD. A P-value of  .05 was considered statis-
tically signficant. Interobserver agreements for assessment
of significant coronary artery (patient, vessel, and segment
based) stenoses were interpreted according to the guide-
lines of Landis and Koch (18).
RESULTS
CTCA and ICA were successfully performed within 7 
15 days in all 88 patients. In 13 patients (14.8%), CTCA
was performed prior to ICA. Forty-one patients (47%) were
on oral -adrenoceptor antagonist medication as part of
their baseline medication. Additional intravenous meto-
prolol was administered in seven patients prior to the CT
examination. Baseline characteristics of the entire study
group and the three subgroups are presented in Table 1.
A total of 351 vessels (1 missing because of an ana-
tomic variant) and 1191 coronary artery segments with a
Table 1
Patient Demographics
All Patients Low Risk for CAD Events
Intermediate Risk for
CAD Events High Risk for CAD Events
Significance
P-Value
No. of patients 88 34 29 25
Female/male (n) 40/48 24/10 10/19 6/19 2: .001
Diabetes (n) 16 1 5 10 2: .001
Nicotine abuse (n) 36 6 17 13 2: .01
Age (y) 64.3  9.4 (39–82) 62.7  11.3 (39–81) 64.4  7.8 (47–79) 66.5 7.9 (49–82) ANOVA: .30
BMI (kg/m2) 23.2 3.9 (13.3–35.8) 22.2 4.7 (13.3–35.8) 23.3 2.9 (18.2–29.7) 24.2 3.9 (18.7–34.0) ANOVA: .17
LDL (mmol/L) 2.9 1.1 (1.4–7.4) 2.4 0.8 (1.5–4.5) 2.9  0.9 (1.4–5.0) 3.7 1.4 (1.5–7.4) ANOVA: .001
HDL (mmol/L) 1.4 0.4 (0.3–2.4) 1.7 0.4 (0.7–2.4) 1.3  0.3 (0.8–2.0) 1.2 0.3 (0.3–1.8) ANOVA: .001
Diastolic BP (mm Hg) 79  12 (45–110) 77 10 (55–96) 77  12 (45–99) 83 12 (60–110) ANOVA: .16
Systolic BP (mm Hg) 135  20 (70–190) 129  18 (70–160) 132  18 (100–167) 147 20 (120–190) ANOVA: .01
Framingham risk score 7 (6, 17) 6 (3, 9) 7 (6, 12) 11 (9, 17) K-W: .001
10-Year risk (%) 11 (7, 40) 6 (5, 9) 11 (11, 18) 24 (22, 40) K-W: .001
At CTCA scanning
HR (beats/min) 63.0 9.2 (46–90) 63.2  8.6 (48–76) 62.2  9.0 (46–78) 63.8  10.4 (47–90) ANOVA: 1.0
HR variability (beats/min) 4.5 4.4 (0.5–22.2) 4.9 4.7 (0.8–22.2) 3.9  4.1 (0.8–16.1) 4.6 4.7 (0.5–18.9) ANOVA: 1.0
Calcium score 173 (5, 635) 90 (1,589) 220 (37, 635) 312 (95, 1196) K-W: .23
Overall image quality
score 1, 2, 3, 4, 5
2 (1, 4)
33, 30, 17, 8, 0
2 (1, 4)
15, 11, 6, 2, 0
2 (1, 4)
13, 7, 6, 3, 0
2 (2, 4)
5, 12, 5, 3, 0
K-W: .25
Best recon. interval
30%, 35%, 40%,
55%, 60%, 65%, 70%
60 (60, 70)
5, 7, 3, 3, 42, 16, 8
60 (60, 70)
2, 3, 0, 1, 19, 5, 4
60 (60, 70)
1, 2, 0, 2, 12, 8, 3
60 (40, 70)
2, 2, 3, 0, 11, 3, 3
K-W: .36
Quantitative variables are expressed as mean  standard deviation (range); categorical variables are expressed as frequencies, or median (25th, 75th percentiles).
BMI, body mass index; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BP, blood pressure; CTCA, computed tomography coronary angiography; HR, heart
rate; recon., reconstruction; K-W, Kruskal-Wallis.
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HUSMANN ET AL Academic Radiology, Vol 15, No 4, April 2008diameter 1.5 mm were evaluated (of 1408 segments, 88
patients, each with coronary 16 segments, 137 segments
were missing because of anatomic variants; 76 segments
had a diameter less than 1.5 mm at their origin). Thirteen
segments (1.1%) were rated not evaluative in CTCA and
were subsequently scored as “false positive” on an inten-
tion-to-diagnose basis.
Diagnostic Accuracy of CTCA: Overall and in
Groups With Low, Intermediate, and High Pretest
Probability for CAD
A total of 114 coronary artery stenoses with a luminal
Figure 1. Demonstration of significant stenosis
in a 62-year-old male patient.
Table 2
Prevalence of CAD in Groups with Low, Intermediate, and High
Analysis
Low Risk for CAD
Events
I
Patient based (n  88) 29.4% (10/34)
Vessel based (n  351) 13.2% (18/136)
Segment based (n  1191) 4.7% (22/466)
CAD, coronary artery disease.narrowing of more than 50% in diameter were identified
456with ICA in 43 of 88 patients (49%) (Fig. 1). Single-ves-
sel disease was present in 16 of 88 (18%), 2-vessel dis-
ease in 14 of 88 (16%), and 3-vessel disease in 13 of 88
(15%) patients. Significant coronary artery stenosis was
excluded in 45 of 88 patients (51%). In groups with low,
intermediate, and high risk for CAD events, the overall
prevalence of CAD was 10 of 34 (29%), 16 of 29 (55%),
and 17 of 25 (68%) patients, respectively; the patient-,
vessel-, and segment-based prevalence of CAD within the
groups is given in Table 2.
Kappa values for interobserver agreement for coronary
artery stenosis detection with CTCA were 0.92, 0.70, and
0.59 (patient, vessel, and segment based), indicating a
wheads) with CTCA (a, b, d, f) and ICA (c, e)
for CAD Events
ediate Risk for
AD Events
High Risk for CAD
Events
Significance
P-Value
2% (16/29) 68.0% (17/25) 2: .01
1% (30/115) 36.0% (36/100) 2: .001
6% (37/386) 16.2% (55/339) 2: .001(arroRisk
nterm
C
55.
26.
9.moderate to excellent agreement.
Academic Radiology, Vol 15, No 4, April 2008 ACCURACY OF CT CORONARY ANGIOGRAPHYCTCA correctly detected 92 of the 114 significant
stenoses (81%), with 41 of 1191 false-positive (3%)
and 22 of 1191 false-negative (2%) ratings on a seg-
ment-based analysis. The vessel-based analysis re-
vealed 19 of 351 false-positive (5%) and 8 of 351
false-negative (2%) ratings. On a patient-based analy-
sis, 8 of 88 false-positive (9%) and 3 of 88 false-nega-
tive (3%) ratings occurred with CTCA overall; in the
groups with low, intermediate, and risk for CAD
events, false-positive ratings were 5 of 34 (15%), 1 of
29 (3%), and 2 of 25 (8%), respectively (P  not sig-
nificant). With regard to the true-negative ratings, CAD
was correctly ruled out with CTCA in 37 of 88 (34%)
patients overall, whereas in the groups with low, inter-
mediate, and high risk for CAD events, the respective
values differed significantly: 19 of 34 (56%), 12 of 29
(41%), and 6 of 25 (24%) (P  .05; Fig. 2).
A detailed overview of the patient-, vessel-, and seg-
ment-based analysis of the diagnostic accuracy of CTCA
overall, and within the three groups with low, intermedi-
ate, and high risk for CAD events, is presented in Table 3.
Figure 2. The proportion (in percent) of true-negative ratings
within each group (ie, the percentage of patients in whom unnec-
essary invasive procedures would have been avoided in a clinical
setting) was highest in the group with low risk for CAD events
and progressively decreased low risk for CAD events.Briefly, sensitivity and specificity of CTCA are not influ-enced by the risk for CAD events, whereas the NPV is
lower (segment based) and the PPV displays a trend to be
higher in patients with a high risk (patient based). Figure
3 demonstrates the PPV and NPV of CTCA with respect
to the risk for CAD events on a per-patient, per-vessel,
and per-segment analysis.
DISCUSSION
According to the Bayesian theorem, diagnostic test
performances depend on the prevalence of the disease.
Although sensitivity and specificity are not affected, the
PPV increases and the NPV decreases when the preva-
lence increases. Therefore, to avoid overestimation of di-
agnostic accuracy in clinical practice, tests should be ap-
plied in settings, comparable to the study conditions.
CTCA is suggested to be used for ruling out CAD pri-
marily in patients with a low and intermediate pretest
probability for CAD (11–13). Nonetheless, diagnostic ac-
curacy of CTCA has mainly been studied in patient popu-
lations with high prevalences of CAD (1–3,5,6,8,10), be-
cause ICA as the reference standard is only justifiable in
populations with high risk for CAD. Only little data have
been published on the topic (19), and our study is the first
to use the recently suggested intention-to-diagnose strat-
egy for evaluation (20), where nonevaluative segments in
CTCA are rated as false-positive findings.
We found that the sensitivity and specificity of CTCA
are not influenced by the risk for CAD events and the
prevalence of CAD, whereas the NPV is lower and the
PPV tends to be higher in patients with a high risk for
CAD events and high prevalence of CAD.
Prevalence of CAD
We stratified the patients using the Framingham score,
resulting in groups with low, intermediate, and high risk
for cardiovascular events. The findings from ICA con-
firmed that this translated into low, intermediate, and high
prevalence of CAD.
In addition, when looking at the diagnostic perfor-
mance of CTCA on a per-patient, per-vessel, and per-
segment basis (Table 3), the numerical interdependence of
patients, vessels, and segments needs to be taken into ac-
count, as the prevalence of disease is highest in the pa-
tient-based analysis and lowest in the segment-based anal-
ysis (Table 2) (i.e., a patient with a single segment steno-
sis will have a patient-based prevalence of disease of
100%, a vessel-based prevalence of 25%, and a segment-
based prevalence of 6%).
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Table 3
Diagnostic Accuracy in Groups with Low, Intermediate, and High Pretest Probability for CAD
All Patients
(absolute values; 95% CI)
Low Risk for CAD Events
(absolute values; 95% CI)
Intermediate Risk for CAD Events
(absolute values; 95% CI)
High Risk for CAD Events
(absolute values; 95% CI)
Significance
P-Value
Patient based:
Sensitivity 93.0% (40/43; 80.9–98.5) 90.0% (9/10; 55.5–98.8) 87.5% (14/16; 61.7–98.5) 100% (17/17; NA) .33
Specificity 82.2% (37/45; 67.9–92.0) 79.2% (19/24; 57.9–92.9) 92.3% (12/13; 63.9–99.8) 75.0% (6/8; 34.9–96.8) .51
NPV 92.5% (37/40; 79.6–98.4) 95.0% (19/20; 75.1–99.9) 85.7% (12/14; 57.2–98.2) 100% (6/6; NA) .45
PPV 83.3% (40/48; 69.8–92.5) 64.3% (9/14; 35.1–87.2) 93.3% (14/15; 68.1–99.8) 89.5% (17/19; 66.9–98.7) .07
Accuracy 87.5% (77/88; 78.7–93.6) 82.4% (28/34; 65.5–93.2) 89.7% (26/29; 72.7–97.8) 92.0% (23/25; 73.9–99.0) .44
Vessel based:
Sensitivity 90.5% (76/84; 82.1–95.8) 94.4% (17/18; 72.7–99.9) 86.7% (26/30; 69.3–96.2) 91.7% (33/36; 77.5–98.3) .64
Specificity 92.9% (248/267; 89.1–95.7) 93.2% (110/118; 87.1–97.0) 95.3% (81/85; 88.4–98.7) 89.1% (57/64; 78.8–95.5) .34
NPV 96.9% (248/256; 93.9–98.6) 99.1% (110/111; 95.1–99.9) 95.3% (81/85; 88.4–98.7) 95.0% (57/60; 86.1–98.9) .20
PPV 80.0% (76/95; 70.5–87.5) 68.0% (17/25; 46.5–85.1) 86.7% (26/30; 69.3–96.2) 82.5% (33/40; 67.2–92.7) .19
Accuracy 92.3% (324/351; 89.0–94.9) 93.4% (127/136; 87.8–96.9) 93.0% (107/115; 86.8–96.9) 90.0% (90/100; 82.4–95.1) .59
Segment based:
Sensitivity 80.7% (92/114; 72.3–87.5) 86.4% (19/22; 65.1–97.1) 83.8% (31/37; 67.9–93.8) 76.4% (42/55; 62.9–86.8) .51
Specificity 96.2% (1036/1077; 94.9–97.3) 96.4% (428/444; 94.2–97.9) 96.6% (337/349; 94.1–98.2) 95.4% (271/284; 92.3–97.5) .73
NPV 97.9% (1036/1058; 96.9–98.7) 99.3% (428/431; 97.9–99.9) 98.3% (337/343; 96.2–99.4) 95.4% (271/284; 92.3–97.5) .01
PPV 69.2% (92/133; 60.6–76.9) 54.3% (19/35; 36.7–71.2) 72.1% (31/43; 56.3–84.7) 76.4% (42/55; 62.9–86.8) .88
Accuracy 94.7% (1128/1191; 93.3–95.9) 95.9% (447/466; 93.7–97.5) 95.3% (368/386; 92.7–97.2) 92.3% (313/339; 88.9–94.9) .06
CAD, coronary artery disease; CI, confidence interval; NA, not available; NS, not significant; NPV, negative predictive value; PPV, positive predictive value.
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Several parameters such as body mass index (3), image
quality (17), coronary calcium score (21), heart rate (21),
and heart rate variability (17) have been suggested to af-
fect sensitivity and specificity of CTCA, whereas it is a
general rule that the prevalence of a disease has no such
impact (22). Nevertheless, in our study, an increasing
prevalence appears to be paradoxically associated with a
nonsignificant trend toward lower specificity. This is in
line with a large body of literature on CTCA (1–3,5,6,8–
10) (Table 4); for example, Meijboom and colleagues
(10) reported a specificity of 75% in a population with a
prevalence of 85%, whereas Ropers and colleagues (9)
found a specificity of 91% in a study with a prevalence of
31% of CAD. Our results support the notion that higher
calcium scores may account for the decreased specificity
in groups with a higher prevalence. In particular, high
Figure 3. (a) PPV of CTCA in comparison to the reference stan-
dard ICA, in groups with low, intermediate, and high risk for CAD
events on a per-patient, per-vessel, and per-segment analysis.
(b) NPV of CTCA in comparison to the reference standard ICA, in
groups with low, intermediate, and high risk for CAD events on a
per-patient, per-vessel, and per-segment analysis.calcium scores, which are generally associated with ahigh prevalence of CAD (23), can often cause blooming
artefacts with subsequent overestimations of the degree of
calcified lesions, leading to false-positive ratings and
lower specificities (24). To improve specificity of CTCA,
in our study, we used a sharp tissue-convolution kernel
for the assessment of calcified coronary lesions, to mini-
mize this overestimating effect (25). However, we evalu-
ated our patients on an intention-to-diagnose basis, rating
all nonevaluative segments as false positive, which, in
contrast, has decreased the overall specificity of CTCA.
The balance of these two opposite effects resulted in a
specificity ranging well within the results reported in the
literature (Table 4) (1–3,5,6,8–10).
Sensitivity of CTCA is generally high and was not
influenced by either the risk for CAD events in our study
or the prevalence as shown in previous 64-slice CTCA
studies (1–3,5,6,8–10) (Table 4).
NPV and PPV of CTCA
A decrease in prevalence was associated with a non-
significant trend toward a low PPV. This holds true for
the prevalence in the three groups as well as for compari-
son of patient-based over vessel-based toward segment-
based analysis due to a decrease in prevalence for numer-
ical reasons. The contrary effect (ie, an increase in the
NPV with falling prevalence) could be substantiated, al-
though the NPV is excellent even with high prevalence of
disease (Fig. 3). Similarly, Hausleiter and colleagues (21)
demonstrated PPV values of CTCA of 65% versus 79%
in two patient populations with Framingham risk scores
below and above an arbitrary cutoff of 12%, stating that
these values did not differ. They also found NPVs not to
differ in both populations, which is in line with our re-
sults on a patient-based analysis. However, on a segment-
based analysis, we demonstrated a significant decrease in
NPVs with an increase of prevalence. Most probably, this
is due to the increased statistical power resulting from
subdividing all vessels of each single patient into 16 seg-
ments.
Clinical Implications
CTCA has been proposed as a “gatekeeper” for ICA
(21). This study shows for the first time that due to its
high NPV, CTCA can be used safely to rule out CAD in
patients with low or intermediate risk as well as those
with high risk for CAD events. Our data suggest that in a
clinical setting, CTCA would have avoided unnecessary
ICA in 56%, 41%, and 24% of patients in the groups
with low, intermediate, and high risk for CAD events
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sending many patients to ICA, as the high number of
avoided ICA by far outweighs the few false-positive val-
ues. The present study underlines that this balance is par-
ticularly favorable in low- and intermediate-risk popula-
tions. Furthermore, we support the suggestion that the
addition of myocardial perfusion imaging should comple-
ment CTCA (26,27) according to best clinical practice
(28) to provide a basis on which a decision to revascular-
ize can be based.
Study Limitations
We acknowledge the following limitations to our
study. First, the Framingham risk score does not take into
account all risk factors for CAD. Nonetheless, the Fra-
mingham risk score is easily assessable and a widely es-
tablished method in clinical routine.
Second, 2-tests for comparison of diagnostic perfor-
mance on a per-vessel and per-segment-basis must be
regarded as an approximation because of data clustering.
However, adequate statistical testing could not be applied
because of small group sizes.
Third, our study was performed using 64-slice CT and
not using most recent dual-source CT scanner technology
Table 4
Diagnostic Accuracy of 64-Slice CTCA
Authors Prevalence (%) Patients (n)
Patient based
Meijboom et al. (10) 85 104
Ehara et al. (8) 88 67
Pugliese et al. (5) 71 35
Leschka et al. (1) 70 67
Nikolaou et al. (6) 57 72
Raff et al. (3) 57 70
Present study 49 88
Leber et al. (2) 42 59
Ropers et al. (9) 31 84
Segment based
Ehara et al. (8) 34 884
Leschka et al. (1) 18 1005
Pugliese et al. (5) 14 494
Nikolaou et al. (6) 13 923
Meijboom et al. (10) 13 1525
Present study 10 1191
Raff et al. (3) 10 935
Leber et al. (2) 8 798
Ropers et al. (9) 4 1083
CTCA, computed tomography coronary angiography; PPV, posit(29). However, if necessary we administered -adreno-
460ceptor antagonists to compensate for the lower temporal
resolution of 64-slice CT.
CONCLUSIONS
The sensitivity and specificity of CTCA are not influ-
enced by risk for CAD events or the prevalence of dis-
ease, whereas the NPV is lower and the PPV tends to be
higher when the risk for CAD events and the prevalence
of disease is high.
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